Patients feel providers do not adequately address concerns about the cost of cancer treatment, which can heighten anxiety during an already stressful time.
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
A new study helps set standards for RNA sequencing, improving standard practice and laying the foundation to move the field forward.
Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.
New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.
Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.